Synthesis of imidazo[1,2-a]pyridine C-nucleosides with an unexpected site of ribosylation

Journal of Organic Chemistry

Volumn 62, Issue 11, 1997, Pages 3453-3459

  Gudmundsson, Kristjan S ^a,b   Drach, John C ^a   Townsend, Leroy B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Tanabe Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMIDAZO[1,2 A]PYRIDINE DERIVATIVE; NUCLEOSIDE DERIVATIVE; ORGANOCHLORINE DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0030922260     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9619342     Document Type: Article

References (30)

1. Watanabe, K. A. In Chemistry of Nucleosides and Nucleotides, Vol. 3; Townsend, L. B., Ed.; Plenum Press: New York, 1994; pp 421-535.
2. Reviews: (a) Jaramillo, C.; Knapp, S. Synthesis 1994, 1-20.
3. (b) Postema, M. H. D. Tetrahedron 1992, 48, 8545-8599.
4. Piccirilli, J. A.; Krauch, T.; MacPherson, L. J.; Banner, S. A. Helv. Chim. Acta 1991, 74, 397-406.
5. Townsend, L. B.; Devivar, R. V.; Turk, S. R.; Nassiri, M. R.; Drach, J. C. J. Med. Chem. 1995, 38, 4098-4105.
6. Dondoni, A; Scherrmann, M. C. J. Org. Chem. 1994, 59, 6404-6412.
7. Paudler, W. H.; Shin, H. G. J. Org. Chem. 1968, 33, 1638-1639.
8. Ishida, Y.; Ohta, K.; Nakahama, T.; Yoshikawa, H. European Patent 0 238 070 A2, 1987.
9. Cheng, J. C.-Y.; Hacksell, U.; Daves, G. D., Jr. J. Org. Chem. 1985, 50, 2778-2780.
10. (a) Timpe, W.; Dax, K.; Wolf, N.; Weidmann, H. Carbohydr. Res. 1975, 39, 53-60.
11. (b) Baker, R.; Fletcher, H. G., Jr. J. Org. Chem. 1961, 26, 4605-4609.
12. Similar α to β ratios upon acetylation in situ or after isolation of the 1′-OH intermediate 7 have been described in the literature for the reaction of ribonolactones with lithiated thiazoles. See ref 5.
13. 1H NMR and mass spectrum as being one of the side products.
14. Calzada, E.; Clarke, C. A.; Roussin-Bouchard, C.; Wightman, R. H. J. Chem. Soc., Perkin Trans. 1995, 517-518.
15. Other deprotection methods such as formic acid in methanol or trifluoroacetic acid in chloroform gave lower yields.
16. Tam, S. Y.-K.; Klein, R. S.; de las Heras, F. G.; Fox, J. J. J. Org. Chem. 1979, 44, 4854-4862.
17. Sokolova, T. N.; Yartseva, I. V.; Preobrazhenskaya, M. N. Carbohydr. Res. 1981, 95, 19-34.
18. MacCoss, M.; Robins, M. J.; Rayner, B.; Imbach, J.-L. Carbohydr. Res. 1977, 59, 575-579.
19. Southon, I. W.; Pfleiderer, W. Chem. Ber. 1978, 111, 996-1005.
20. MacCoss, M.; Meurer, L. C.; Hoogsteen, K.; Springer, J. P.; Koo, G.; Peterson, L. B.; Tolman, R. L.; Emini, E. J. Heterocycl. Chem. 1993, 30, 1213-1220.
21. (a) Ohta, K; Ishida, Y.; Yoshikawa, H. European Patent 0 383 319 A2, 1990.
22. (b) Ohta, K.; Minami, K.; Yoshikawa, H; Ishida, Y. Biosci. Biotech. Biochem. 1993, 57, 1844-1848.
23. Katsura, Y.; Nishino, S.; Inoue, Y.; Tomoi, M.; Takasugi, H. Chem. Pharm. Bull. 1992, 40, 371-380.
24. Katsura, Y.; Nishino, S.; Takasugi, H. Chem. Pharm. Bull. 1991, 39, 2937-2943.
25. For reviews, see: (a) Blewitt, H. L. In Special Topics in Heterocyclic Chemistry, Vol. 30; Weissberger, A., Taylor, E. C., Eds.; John Wiley: New York, 1977; pp 117-178.
26. (b) Montgomery, J. A.; Secrist, J., III. In Comprehensive Heterocyclic Chemistry; Katritzky, A. R., Rees, C. W., Eds.; Pergamon Press: New York, 1984; Vol. 5, pp 607-668.
27. Hand, E. H.; Paudler, W. W. J. Org. Chem. 1978, 43, 2900-2906.
28. Turk, S. R.; Shipman, C., Jr.; Nassiri, R.; Genzlinger, G.; Krawczyk, S. H.; Townsend, L. B.; Drach, J. C. Antimicrob. Agents Chemother. 1987, 31, 544-550.
29. Prichard, M. N.; Shipman, C., Jr. Antiviral Res. 1990, 14, 181-206.
30. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.